Watchlist Price Alert

BriaCell Therapeutics Cor... (BCTXZ)

NASDAQ: BCTXZ · Real-Time Price · USD

0.99

0.02 (1.57%)

At close: Jun 13, 2025, 3:59 PM

0.99

0.00%

After-hours: Jun 13, 2025, 04:00 PM EDT

BriaCell Therapeutics Warrant Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Oct 31, 2020	Jul 31, 2020	Apr 30, 2020	Jan 31, 2020	Oct 31, 2019	Jul 31, 2019	Apr 30, 2019	Jan 31, 2019	Oct 31, 2018	Jul 31, 2018	Apr 30, 2018	Jan 31, 2018	Oct 31, 2017	Jul 31, 2017	Apr 30, 2017	Jan 31, 2017	Oct 31, 2016	Jul 31, 2016	Apr 30, 2016	Jan 31, 2016	Oct 31, 2015
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-7.17M	-5.15M	-7.17M	-5.15M	-5.77M	-9.23M	-7.71M	-5.68M	-7.71M	-5.68M	-4.49M	-4.12M	-3.65M	-2.29M	-3.65M	-2.29M	-1.59M	-380K	-190K	-501K	-625K	-501.4K	-1.42M	-1.17M	-1.38M	-1.11M	-1.36M	-980K	-798K	-503K	-798K	-503K	-1.08M	-325K	-206K	-272.51K	-206K	-273K
Interest Income	46.83K	13.05K	n/a	13.05K	n/a	15.61K	81.59K	253.49K	240.59K	188.35K	82.36K	35.99K	12.08K	6.3K	12.08K	6.3K	n/a	n/a	n/a	n/a	n/a	n/a	211.25	499.40	5.33K	499.40	5.33K	1.79K	456.34	1.79K	456.34	1.07K	2.73K	71.56	744.52	71.56	258.27	245.34
Pretax Income	-6.34M	-5.83M	-6.34M	1.69M	-1.25M	1.69M	-11.33M	-4.89M	-11.88M	-4.89M	-15.75M	-10.02M	-15.75M	-27.53M	11.16M	-27.53M	-236K	-421K	-236K	-421K	-624K	-504.92K	-1.42M	-1.25M	-1.36M	-1.13M	-1.21M	-798K	-1.61M	-1.29M	-1.09M	-861K	-1.09M	-327K	-316K	-340.68K	-714K	-308K
Net Income	-6.29M	-5.8M	-1.21M	-5.8M	-11.29M	6M	-11.29M	-4.89M	-11.88M	-1.11M	-15.75M	-10.02M	11.16M	-27.53M	-2.72M	2.95M	-236K	-421K	-236K	-421K	-624K	-504.92K	-1.42M	-1.25M	-1.36M	-1.13M	-1.21M	-798K	-787K	-500K	-1.09M	-861K	-316.33K	-327K	-239K	-340.68K	-714K	-308K
Selling & General & Admin	1.49M	1.49M	1.36M	1.57M	1.36M	1.65M	1.57M	1.82M	1.43M	1.82M	1.37M	1.85M	1.94M	1.41M	1.94M	1.41M	20.74K	227.49K	203.29K	295.04K	203.29K	414.33K	497.87K	414.33K	303.58K	219.53K	510.62K	219.53K	186.37K	138.61K	186.37K	293.98K	174.03K	293.98K	174.03K	251.52K	624.56K	251.52K
Research & Development	5.68M	3.67M	4.41M	7.66M	4.41M	6.86M	5.17M	3.86M	3.05M	3.25M	3.05M	2.27M	1.71M	875.64K	594.44K	875.64K	165.59K	149.06K	418.07K	202.99K	418.07K	756.12K	1.06M	784.88K	1.18M	757.02K	917.78K	757.02K	611.42K	364.41K	611.42K	565.55K	164.05K	565.55K	164.05K	197.63K	636.68K	150.1K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-11.45K	n/a	n/a	n/a	3.8K	3.81K	3.81K	3.82K	3.84K	3.82K	3.54K	3.56K	14.25K	3.56K	14.25K	3.48K	12.97K	3.57K	12.97K	n/a	n/a	n/a	-0.00	n/a	n/a	-0.00	892.44	224.09
Operating Expenses	7.17M	5.15M	5.77M	9.23M	5.77M	8.5M	7.71M	5.68M	4.49M	5.4M	4.23M	4.12M	3.65M	2.29M	3.65M	4.81M	190.15K	380.37K	625.2K	380.37K	1.42M	1.17M	1.38M	1.11M	1.36M	1.11M	1.44M	980.13K	797.79K	1.11M	1.08M	503.02K	1.08M	325.02K	338.08K	272.51K	205.63K	272.51K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	979.00	n/a	979.00	45.79K	15.72K	18.96K	3.56K	2.99K	1.71K	4.23K	2.38K	4.23K	10.14K	7.49K	10.14K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	7.17M	5.15M	7.17M	5.15M	5.77M	9.23M	7.71M	5.68M	7.71M	5.68M	4.49M	4.12M	3.65M	2.29M	1.59M	4.81M	1.59M	380.37K	190.15K	501.4K	625.2K	1.17M	1.42M	1.17M	1.38M	1.11M	1.36M	980.13K	1.44M	1.11M	1.08M	859.53K	1.08M	859.53K	338.08K	325.02K	775.31K	312.46K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Diluted)	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA	-7.14M	-5.13M	-7.14M	-9.23M	-5.7M	-8.5M	-2.42M	-5.67M	-4.48M	-5.4M	-15.74M	-10.01M	-15.74M	-27.53M	11.16M	-27.53M	-186K	-402K	-186K	-402K	-601K	-497.98K	-1.42M	-1.25M	-1.35M	-1.13M	-1.19M	-772K	-1.75M	-1.11M	-1.07M	-500K	-1.07M	-325K	-338K	-324.8K	-775K	-312K
EBIT	-7.17M	-5.15M	-7.17M	-5.15M	-5.77M	-9.23M	-2.42M	-5.68M	-2.42M	-5.68M	-15.75M	-10.02M	-15.75M	-27.53M	11.16M	-27.53M	-190K	-406K	-190K	-406K	-605K	-501.36K	-1.42M	-1.25M	-1.36M	-1.13M	-1.2M	-788K	-1.76M	-1.11M	-1.07M	-860K	-338.08K	-325K	-206K	-272.51K	-206K	-273K
Depreciation & Amortization	26.66K	26.66K	26.66K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.82K	3.81K	3.81K	3.81K	3.81K	3.84K	3.04K	3.84K	3.56K	3.53K	3.56K	3.81K	-9.53K	3.53K	16.45K	12.97K	n/a	-417	202.84	229.52	217.66	431.66	217.66	431.66	224.09